Floatz logo

Human Fibrinogen

Periampullary Adenocarcinoma

Asan Medical Centerprotein_peptidePhase 4 / ApprovedDormant
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Periampullary Adenocarcinoma cohort.

Asset / SponsorPhaseRating
N-Butyl Cyanoacrylate
Minia University
Phase 3BB
Xaliplatin
National Cancer Institute (NCI)
Phase 2B
Fluorouracilum
National Cancer Institute (NCI)
Phase 2CCC
Cis-Diamminedichloroplatinum Ii
New Mexico Cancer Research Alliance
Phase 2CCC
Cediranib
National Cancer Institute (NCI)
Phase 2CCC

View all 12 →

Same molecule, other indications

Human Fibrinogen is also rated in:

hemorrhagic diseaseDormant
BB
Indicative · Phase 4
65 / 100
View asset →
intracerebral hemorrhageActive
BB
Indicative · Phase 3
64 / 100
View asset →
pancreatic neoplasmDormant
B
Indicative · Phase 4
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →